HPSE and type 2 diabetes mellitus: et al. demonstrated that the heparanase inhibitor SST0001 reduced albuminuria in T2D mice and further determined that heparanase upregulation in DKD results from activation of the heparanase promoter by the transcription factor early growth response-1 (Egr1) [60].